These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3902461)

  • 1. Niridazole: Evidence for promutagenic events involving guanine-cytosine and adenine-thymine base pairs.
    Speck WT; Carr HS; Rosenkranz HS
    Environ Mutagen; 1985; 7(4):429-37. PubMed ID: 3902461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of genotype on mutagenicity of niridazole in nitroreductase-deficient bacteria.
    Speck WT; Blumer JL; Rosenkranz EJ; Rosenkranz HS
    Cancer Res; 1981 Jun; 41(6):2305-7. PubMed ID: 7016312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative importance of bacterial and mammalian nitroreductases for niridazole mutagenesis.
    Blumer JL; Friedman A; Meyer LW; Fairchild E; Webster LT; Speck WT
    Cancer Res; 1980 Dec; 40(12):4599-605. PubMed ID: 6893679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice.
    Legator MS; Connor TH; Stoeckel M
    Science; 1975 Jun; 188(4193):1118-9. PubMed ID: 766186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and quantum chemical basis of the mutagenicity of nitroarenes for adenine-thymine base pairs.
    McCoy EC; Holloway M; Frierson M; Klopman G; Mermelstein R; Rosenkranz HS
    Mutat Res; 1985 May; 149(3):311-9. PubMed ID: 3887141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mutagenic activity of nitrothiazole compounds].
    Hof H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Jun; 181(1-2):64-70. PubMed ID: 3901605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenesis by N-nitroso compounds in Salmonella typhimurium TA102 and TA104: evidence for premutagenic adenine or thymine DNA adducts.
    Guttenplan JB; Hu YC
    Mutat Res; 1984; 141(3-4):153-9. PubMed ID: 6392880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic activity of 4 active-principle forms of pharmaceutical drugs. Comparative study in the Salmonella typhimurium microsome test, and the HGPRT and Na+/K+ ATPase systems in cultured mammalian cells.
    Dayan J; Crajer MC; Deguingand S
    Mutat Res; 1982; 102(1):1-12. PubMed ID: 6289090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxic activity of nitroaromatic explosives and related compounds in Salmonella typhimurium.
    Whong WZ; Edwards GS
    Mutat Res; 1984 Jun; 136(3):209-15. PubMed ID: 6377057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that nitroarene metabolites form mutagenic adducts with DNA-adenine as well as with DNA-guanine.
    Massaro M; McCartney M; Rozenkranz EJ; Anders M; McCoy EC; Mermelstein R; Rosenkranz HS
    Mutat Res; 1983 Dec; 122(3-4):243-9. PubMed ID: 6361534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the existence of distinct nitroreductases in Salmonella typhimurium: roles in mutagenesis.
    Rosenkranz EJ; McCoy EC; Mermelstein R; Rosenkranz HS
    Carcinogenesis; 1982; 3(1):121-3. PubMed ID: 7039852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-mediated mutagenicity of mononitrobenzo[a]pyrenes in Salmonella typhimurium strains.
    Hass BS; Heflich RH; Chou MW; White GL; Fu PP; Casciano DA
    Mutat Res; 1986; 171(2-3):123-9. PubMed ID: 3528834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagen screening with bacteria: niridazole and nitrofurans.
    McCalla DR; Voutsinos D; Olive PL
    Mutat Res; 1975 Feb; 31(1):31-7. PubMed ID: 1093013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium.
    Schmeiser HH; Pool BL; Wiessler M
    Cancer Lett; 1984 May; 23(1):97-101. PubMed ID: 6378360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitroreduction in the synergistic mutational response induced by mixtures of 1- and 3-nitrobenzo[a]pyrene in Salmonella typhimurium.
    Thornton-Manning JR; Campbell WL; Hass BS; Chen JJ; Fu PP; Cerniglia CE; Heflich RH
    Environ Mol Mutagen; 1989; 13(3):203-10. PubMed ID: 2651117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of a series of 25 nitroimidazoles and two nitrothiazoles in Salmonella typhimurium.
    Cantelli-Forti G; Aicardi G; Guerra MC; Barbaro AM; Biagi GL
    Teratog Carcinog Mutagen; 1983; 3(1):51-63. PubMed ID: 6132457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. III. Methylated derivatives of 9H-carbazole.
    André V; Boissart C; Sichel F; Gauduchon P; Le Talaër JY; Lancelot JC; Mercier C; Chemtob S; Raoult E; Tallec A
    Mutat Res; 1997 Mar; 389(2-3):247-60. PubMed ID: 9093391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichotomy in the mutagenicity and genotoxicity of nitropyrenes: apparent effect of the number of electrons involved in nitroreduction.
    Eddy EP; McCoy EC; Rosenkranz HS; Mermelstein R
    Mutat Res; 1986 Jul; 161(2):109-11. PubMed ID: 3523222
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutagenic activity and specificity of N-nitrosomethylaniline and N-nitrosodiphenylamine in Salmonella.
    Zielenska M; Guttenplan JB
    Mutat Res; 1988 Nov; 202(1):269-76. PubMed ID: 3054528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.